The invention discloses an intestinal microbial marker for predicting adverse reaction after
chemotherapy of gastric
cancer. The intestinal microbial marker comprises at least one of
Kluyveromyces, Torula, Piptocephalis and Paraiisaria. The invention further discloses a preparation method of the intestinal microbial marker for predicting the adverse reaction after
chemotherapy of the gastric
cancer. In the invention, the intestinal microbiota composition of a
bone marrow suppression group after gastric
cancer chemotherapy and a
bone marrow suppression-free group after gastric
cancer chemotherapy are deeply studied, and a related
flora combination capable of predicting
bone marrow suppression after gastric
cancer chemotherapy, namely four florae of
Kluyveromyces, Torula, Piptocephalis and Paraiisaria, is screened by utilizing 16SrDNA (
Deoxyribose Nucleic Acid) sequencing on the
genus level. According to the invention, a
Logistic regression prediction model is established, the accuracy of predicting the adverse reaction of gastric
cancer chemotherapy by the differential
genus is evaluated, and whether the
area under curve (AUC) in myelosuppression is 70.9% [95% CI, 54.9%-86.9%] after chemotherapy is predicted. It is indicated that the prediction model of the differential bacterial
genus combination has good prediction capacity, myelosuppression after chemotherapy can be discriminated in the early stage,
intervention measures are taken in time to prevent deterioration of symptoms, and the method has important reference significance in clinic.